ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesCombioxin SA
Combioxin SA Logo
Verified· 3 sources

Combioxin SA

Summary

About the company

The core activity of Combioxin SA is the development of life-saving medications for severe infections, particularly for the treatment of severe bacterial pneumonias. The company focuses on the development of innovative therapeutics, such as CAL02, a first-in-class anti-toxin agent used to neutralize virulence factors that play a crucial role in the development of organ failure and fatal complications in severe infections.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered2
Antivirulence drug (CAL02)
CAL02, a broad-acting, first-in-class antivirulence active ingredient in development for the treatment of severe community-acquired bacterial pneumonia; with proprietary liposomes for neutralising bacterial toxins.
Therapy for acquired immunodeficiency in critically ill patients
Therapeutic approach in development for the treatment of acquired immunodeficiency in the intensive care unit, with restoration of immune function and immune balance as an add-on therapy.
Press

Media

June 30, 2026Media
Three Swiss biotech companies secure grants
startupticker.ch
Comparisons

Combioxin SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Combioxin SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Combioxin SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route de la Corniche 8
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-310.572.972
Founded
2015 · 11 years
Last commercial register change
June 15, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Combioxin SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AG
Alithea Genomics SA
Epalinges
AT
ADC Therapeutics SA
Epalinges
NB
ND BioSciences SA
Epalinges
NS
Novassay SA
Epalinges
NS
NewBiologix SA
Epalinges
VS
VivoArchitect Sàrl
Epalinges
DI
Debiopharm International SA
Lausanne
CS
Copexis SA
La Conversion